US3208908A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Fibrinolysin-desoxyribonuclease for enzymatic debridement
Assignee: Parke Davis and Co LLC
•
Filing: 1961-11-16
•
Granted: 1965-09-28
•
Expires: 1981-11-16
Abstract
No abstract record available.
Inventors
- 👤 Richard E Maxwell
- 👤 Eugene C Loomis
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 02:25
CPC Classifications
H; H01; H01M; H01M10/00; H01M10/34; A; A61; A61K; A61K38/00; A61K38/16; A61K38/43; A61K38/46; A61K38/465; A61K38/48; A61K38/482; A61K38/484; Y; Y02; Y02E; Y02E60/00; Y02E60/10
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
32 words
A THERAPEUTIC COMPOSITION FOR ENZYMATIC DEBRIDEMENT COMPRISING, IN COMBINATION, FIBRINOLYSIN AND DESOXYRIBONUCLEASE, SAID FIBRINOLYSIN AND SAID DESOXYRIBONUCLEASE BEING PRESENT IN A RATIO OF 1 UNIT OF FIBRINOLYSIN TO 20-5000 UNITS OF DESOXYRIBONUCLEASE.
Claim 2
Dependent Claim
32 words
A THERAPEUTIC COMPOSITION FOR ENZYMATIC DEBRIDEMENT COMPRISING, IN COMBINATION, FIBRINOLYSIN AND DESOXYRIBONUCLEASE, SAID FIBRINOLYSIN AND SAID DESOXYRIBONUCLEASE BEING PRESENT IN A RATIO OF 1 UNIT OF FIBRINOLYSIN TO 20-5000 UNITS OF DESOXYRIBONUCLEASE.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1968-09-27 | 1969-03-29 | 1969-09-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1972-09-27 | 1973-03-29 | 1973-09-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1976-09-27 | 1977-03-29 | 1977-09-28 | $7700.00 | Window Closed / Lapsed |